ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Histone demethylase JMJD3 protects against renal fibrosis by suppressing TGFβ and Notch signaling and preserving PTEN expression

Yu, Chao; Xiong, Chongxiang; Tang, Jinhua; Hou, Xiying; Liu, Na; Bayliss, George; Zhuang, Shougang*南方医科大学; 同济大学
2021DOI: 10.7150/thno.48679
34被引4阅读
引用收藏
分享

摘要

Rationale: The Jumonji domain containing-3 (JMJD3), a specific histone demethylase for trimethylation on histone H3 lysine 27 (H3K27me3), is associated with the pathogenesis of many diseases, but its role in renal fibrosis remains unexplored. Here we examined the role of JMJD3 and mechanisms involved in the activation of renal fibroblasts and development of renal fibrosis. @@@ Methods: Murine models of 5/6 surgical nephrectomy (SNx) and ureteral unilateral obstruction (UUO) were used to assess the effect of a specific JMJD3 inhibitor, GSKJ4, and genetic deletion of JMJD3 from FOXD1 stroma-derived renal interstitial cells on the development of renal fibrosis and activation of renal interstitial fibroblasts. Cultured rat renal interstitial fibroblasts (NRK-49F) and mouse renal tubular epithelial cells (mTECs) were also used to examine JMJD3-mediated activation of profibrotic signaling. @@@ Results: JMJD3 and H3K27me3 expression levels were upregulated in the kidney of mice subjected to SNx 5/6 and UUO. Pharmacological inhibition of JMJD3 with GSKJ4 or genetic deletion of JMJD3 led to worsening of renal dysfunction as well as increased deposition of extracellular matrix proteins and activation of renal interstitial fibroblasts in the injured kidney. This was coincident with decreased expression of Smad7 and enhanced expression of H3K27me3, transforming growth factor beta 1 (TGF beta 1), Smad3, Notch1, Notch3 and Jagged1. Inhibition of JMJD3 by GSK J4 or its specific siRNA also resulted in the similar responses in cultured NRK-49F and mTECs exposed to serum or TGF beta 1. Moreover, JMJD3 inhibition augmented phosphorylation of AKT and ERK1/2 in vivo and in vitro. @@@ Conclusion: These results indicate that JMJD3 confers anti-fibrotic effects by limiting activation of multiple profibrotic signaling pathways and suggest that JMJD3 modulation may have therapeutic effects for chronic kidney disease.

学科与关键词

关键词
Jumonji domain containing-3renal fibrosisextracellular matrixrenal interstitial fibroblasts5/6 nephrectomyureteral unilateral obstruction
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
发表日期
2021
卷期
第 11 卷, 第 6 期
页码
2706-2721
DOI
10.7150/thno.48679
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81670623, 82070700, 81830021, 81970585]; National key R&D Program of China [2018YFA0108802]; US National Institutes of Health [2R01DK08506505A1]

作者

  • Y

    Yu, Chao (第一作者)

    tongji univ

  • X

    Xiong, Chongxiang

    southern med univ

查看全部 7 位作者收起作者
  • T

    Tang, Jinhua

    tongji univ

  • H

    Hou, Xiying

    tongji univ

  • L

    Liu, Na

    tongji univ

  • B

    Bayliss, George

  • Z

    Zhuang, Shougang (通讯)

    tongji univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417